Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
SURGERY	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
left	O
venous	O
stasis	O
ulcer	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
History	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
with	O
history	O
of	O
chronic	O
L	O
medial	O
malleolus	O
ulcer	O
since	O
___	O
per	O
clinic	O
note.	O
She	O
presents	O
from	O
clinic	O
for	O
wound	O
care/IV	O
antibiotics.	O
She	O
reports	O
today	O
that	O
she	O
has	O
had	O
this	O
left	O
medial	O
malleolus	O
ulcer	O
that	O
has	O
been	O
stable	O
for	O
the	O
past	O
___	O
years.	O
Denies	O
any	O
inciting	O
trauma,	O
fevers/chills,	O
paresthesias.	O
She	O
presents	O
from	O
clinic	O
for	O
evaluation	O
of	O
chronic	O
wound.	O
She	O
has	O
a	O
___	O
year	O
history	O
of	O
smoking	O
___	O
cigarettes	O
per	O
day	O
but	O
quit	O
___	O
years	O
ago.	O
She	O
denies	O
hx	O
of	O
DM,	O
HTN,	O
hypercholesterolemia.	O
Past	O
Medical	O
History:	O
Past	O
Medical	O
Hx:	O
-	O
Pyschosis	O
-	O
Hyperlipidemia	O
-	O
Osteopenia/Osteoporosis	O
-	O
Vitamin	O
D	O
Deficiency	O
-	O
Chronic	O
leg	O
ulcer	O
Past	O
Psychiatric	O
Hx:	O
-	O
Diagnoses:	O
unclear,	O
likely	O
schizophrenia	O
vs	O
schizotypal	O
personality	O
disorder	O
-	O
Hospitalizations:	O
___	O
at	O
___,	O
___	O
at	O
___	O
HRI	O
-	O
Psychiatrist:	O
none	O
-	O
Therapist:	O
none	O
-	O
Medication	O
Trials:	O
Risperidone	O
3mg	O
PO	O
QPM	O
___	O
___	O
hospitalization;	O
patient	O
no	O
longer	O
takes)	O
Past	O
Surgical	O
Hx:	O
-	O
Rhinoplasty	O
___	O
-	O
Tonsillectomy	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Psychiatric	O
FHx:	O
-	O
Diagnoses:	O
denies	O
-	O
Suicides:	O
denies	O
-	O
Addictions:	O
denies	O
Medical	O
FHx:	O
-	O
Mother	O
cirrhosis,	O
deceased	O
at	O
___	O
-	O
Father	O
pacemaker	O
placement,	O
sepsis,	O
deceased	O
at	O
___	O
-	O
Sister	O
MI,	O
lung	O
cancer,	O
living	O
age	O
___	O
Physical	O
Exam:	O
On	O
discharge:	O
Gen:	O
NAD,	O
AOx3,	B-Dementia
resting	O
in	O
bed	O
Pulm:	O
Normal	O
work	O
of	O
breathing	O
on	O
room	O
air,	O
no	O
respiratory	O
distress	O
Wound:	O
medial	O
malleolus	O
ulcer	O
of	O
LLE	O
with	O
fibrinous	O
exudates,	O
erythema,	O
with	O
wet	O
to	O
dry	O
dressing	O
c/d/i	O
Ext:	O
WWP	O
Pertinent	O
Results:	O
Labs-----------	O
___	O
09:32AM	O
BLOOD	O
WBC-4.8	O
RBC-4.60	O
Hgb-13.2	O
Hct-40.7	O
MCV-89	O
MCH-28.7	O
MCHC-32.4	O
RDW-15.8*	O
RDWSD-51.3*	O
Plt	O
___	O
___	O
09:32AM	O
BLOOD	O
Glucose-95	O
UreaN-12	O
Creat-0.7	O
Na-142	O
K-4.4	O
Cl-105	O
HCO3-21*	O
AnGap-16	O
___	O
09:32AM	O
BLOOD	O
Calcium-8.9	O
Phos-2.6*	O
Mg-2.2	O
Imaging-------------	O
Venous	O
Duplex	O
Study	O
___	O
No	O
DVT	O
b/l;	O
No	O
axial	O
reflux	O
in	O
deep	O
or	O
superficial	O
veins	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
presented	O
to	O
___	O
holding	O
at	O
___	O
on	O
___	O
from	O
clinic	O
for	O
wound	O
care	O
and	O
IV	O
antibiotics	O
for	O
the	O
left	O
medial	O
malleolus	O
venous	O
stasis	O
ulcer.	O
This	O
was	O
a	O
nonoperative	O
wound	O
and	O
she	O
was	O
transitioned	O
to	O
oral	O
antibiotics	O
without	O
complication.	O
Neuro:	O
Pain	O
was	O
well	O
controlled	O
on	O
oral	O
medication.	O
CV:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
cardiovascular	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
Pulm:	O
The	O
patient	O
remained	O
stable	O
from	O
a	O
pulmonary	O
standpoint;	O
oxygen	O
saturation	O
was	O
routinely	O
monitored.	O
GI:	O
The	O
patient	O
had	O
intermittent	O
nausea	O
that	O
resolved	O
with	O
change	O
of	O
IV	O
antibiotics	O
to	O
p.o.'s	O
at	O
the	O
time	O
of	O
discharge.	O
Patient's	O
intake	O
and	O
output	O
were	O
closely	O
monitored	O
GU:	O
At	O
time	O
of	O
discharge,	O
the	O
patient	O
was	O
voiding	O
without	O
difficulty.	O
ID:	O
The	O
patient	O
was	O
closely	O
monitored	O
for	O
signs	O
and	O
symptoms	O
of	O
infection	O
and	O
fever.	O
Heme:	O
The	O
patient	O
had	O
blood	O
levels	O
checked	O
daily	O
during	O
their	O
hospital	O
course	O
to	O
monitor	O
for	O
signs	O
of	O
bleeding.	O
The	O
patient	O
received	O
subcutaneous	O
heparin	O
and	O
___	O
dyne	O
boots	O
were	O
used	O
during	O
this	O
stay,	O
he/she	O
was	O
encouraged	O
to	O
get	O
up	O
and	O
ambulate	O
as	O
early	O
as	O
possible.	O
On	O
___,	O
the	O
patient	O
was	O
discharged	O
to	O
assisted	O
living	O
with	O
continued	O
___	O
follow-up	O
for	O
daily	O
dressing	O
changes.	O
At	O
discharge,	O
she	O
was	O
tolerating	O
a	O
regular	O
diet,	O
passing	O
flatus,	O
voiding,	O
and	O
ambulating	B-Independently_mobile
independently.	B-Independently_mobile
She	O
will	O
follow-up	O
in	O
the	O
clinic	O
in	O
___	O
weeks.	O
This	O
information	O
was	O
communicated	O
to	O
the	O
patient	O
directly	O
prior	O
to	O
discharge.	O
Medications	O
on	O
Admission:	O
Medications	O
-	O
Prescription	O
ALENDRONATE	O
-	O
alendronate	O
70	O
mg	O
tablet.	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
week	O
for	O
osteoporosis.	O
Take	O
pill	O
first	O
thing	O
with	O
a	O
glass	O
of	O
water,	O
don't	O
lie	O
down	O
for	O
an	O
hour.	O
CEPHALEXIN	O
-	O
cephalexin	O
500	O
mg	O
capsule.	O
1	O
capsule(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
COLLAGENASE	O
CLOSTRIDIUM	O
HISTO.	O
[SANTYL]	O
-	O
Santyl	O
250	O
unit/gram	O
topical	O
ointment.	O
apply	O
to	O
affected	O
area	O
daily	O
Apply	O
to	O
affected	O
area	O
daily	O
with	O
dressing	O
change	O
-	O
(Not	O
Taking	O
as	O
Prescribed)	O
Medications	O
-	O
OTC	O
ACETAMINOPHEN	O
-	O
Dosage	O
uncertain	O
-	O
(Prescribed	O
by	O
Other	O
Provider)Entered	O
by	O
MA/Other	O
Staff	O
BISACODYL	O
-	O
Dosage	O
uncertain	O
-	O
(Prescribed	O
by	O
Other	O
Provider)Entered	O
by	O
MA/Other	O
Staff	O
CALCIUM	O
CARBONATE	O
-	O
calcium	O
carbonate	O
500	O
mg	O
calcium	O
(1,250	O
mg)	O
tablet.	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
-	O
(Prescribed	O
by	O
Other	O
Provider:	O
___	O
discharge	O
)	O
CALCIUM	O
CARBONATE-VITAMIN	O
D3	O
[CALCIUM	O
600	O
+	O
D(3)]	O
-	O
Dosage	O
uncertain	O
-	O
(Prescribed	O
by	O
Other	O
Provider)Entered	O
by	O
MA/Other	O
Staff	O
CHOLECALCIFEROL	O
(VITAMIN	O
D3)	O
[VITAMIN	O
D3]	O
-	O
Dosage	O
uncertain	O
-	O
(Prescribed	O
by	O
Other	O
Provider)Entered	O
by	O
MA/Other	O
Staff	O
ERGOCALCIFEROL	O
(VITAMIN	O
D2)	O
-	O
ergocalciferol	O
(vitamin	O
D2)	O
400	O
unit	O
tablet.	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
-	O
(Prescribed	O
by	O
Other	O
Provider:	O
___	O
discharge)	O
MAGNESIUM	O
HYDROXIDE	O
[MILK	O
OF	O
MAGNESIA]	O
-	O
Dosage	O
uncertain	O
-	O
(Prescribed	O
by	O
Other	O
Provider)Entered	O
by	O
MA/Other	O
Staff	O
SODIUM	O
PHOSPHATES	O
[FLEET	O
ENEMA]	O
-	O
Dosage	O
uncertain	O
-	O
(Prescribed	O
by	O
Other	O
Provider)Entered	O
by	O
MA/Other	O
Staff	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H	O
RX	O
*acetaminophen	O
325	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
every	O
6	O
hours	O
PRN	O
Disp	O
#*75	O
Capsule	O
Refills:*0	O
2.	O
Amoxicillin-Clavulanic	O
Acid	O
___	O
mg	O
PO	O
Q12H	O
RX	O
*amoxicillin-pot	O
clavulanate	O
875	O
mg-125	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*28	O
Tablet	O
Refills:*0	O
3.	O
Alendronate	O
Sodium	O
70	O
mg	O
PO	O
QMON	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
L	O
medial	O
malleolus	O
venous	O
stasis	O
ulcer	O
Discharge	O
Condition:	O
Stable,	O
alert	O
and	O
oriented	B-Delirium
x3,	B-Delirium
ambulating	B-Mobile_with_assistance
without	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
to	O
___	O
for	O
wound	O
care	O
of	O
your	O
L	O
medial	O
malleolus	O
venous	O
stasis	O
ulcer.	O
You	O
were	O
treated	O
with	O
IV	O
antibiotics	O
and	O
transitioned	O
to	O
oral	O
antibiotics.	O
We	O
continued	O
local	O
wound	O
care	O
of	O
your	O
left	O
ankle,	O
with	O
twice	O
daily	O
moist	O
to	O
dry	O
dressing	O
changes.	O
You	O
should	O
continue	O
these	O
dressing	O
changes	O
and	O
a	O
2	O
week	O
course	O
of	O
oral	O
antibiotics.	O
You	O
may	O
shower,	O
and	O
may	O
take	O
acetaminophen	O
625	O
mg	O
every	O
6	O
hours	O
as	O
needed	O
for	O
pain.	O
If	O
you	O
see	O
any	O
swelling,	O
abnormal	O
drainage,	O
increased	O
redness,	O
increased	O
growth	O
of	O
the	O
wound,	O
start	O
to	O
feel	O
feverish/chilled	O
or	O
have	O
any	O
other	O
symptoms	O
that	O
concern	O
you,	O
you	O
should	O
call	O
___	O
and	O
go	O
to	O
your	O
local	O
emergency	O
department	O
if	O
indicated.	O
Followup	O
Instructions:	O
___	O

